231 related articles for article (PubMed ID: 17435612)
1. Postmenopausal tibolone therapy: biologic principles and applied clinical practice.
Notelovitz M
MedGenMed; 2007 Jan; 9(1):2. PubMed ID: 17435612
[TBL] [Abstract][Full Text] [Related]
2. Tibolone: the way to beat many a postmenopausal ailments.
Lazovic G; Radivojevic U; Marinkovic J
Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345
[TBL] [Abstract][Full Text] [Related]
3. Spanish Menopause Society position statement: use of tibolone in postmenopausal women.
Mendoza N; Abad P; Baró F; Cancelo MJ; Llaneza P; Manubens M; Quereda F; Sánchez-Borrego R
Menopause; 2013 Jul; 20(7):754-60. PubMed ID: 23793166
[TBL] [Abstract][Full Text] [Related]
4. Effects of tibolone on the breast of postmenopausal women.
Wang PH; Cheng MH; Chao HT; Chao KC
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):121-6. PubMed ID: 17638619
[TBL] [Abstract][Full Text] [Related]
5. Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: Evidence of progestogenic effects.
Schatz F; Kuczynski E; Kloosterboer HJ; Buchwalder L; Tang C; Krikun G; Lockwood CJ
Steroids; 2005 Nov; 70(12):840-5. PubMed ID: 16011840
[TBL] [Abstract][Full Text] [Related]
6. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
Reginster JY
J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
[TBL] [Abstract][Full Text] [Related]
7. Tibolone and its effects on bone: a review.
Berning B; Bennink HJ; Fauser BC
Climacteric; 2001 Jun; 4(2):120-36. PubMed ID: 11428176
[TBL] [Abstract][Full Text] [Related]
8. Selective tissue distribution of tibolone metabolites in mature ovariectomized female cynomolgus monkeys after multiple doses of tibolone.
Verheul HA; van Iersel ML; Delbressine LP; Kloosterboer HJ
Drug Metab Dispos; 2007 Jul; 35(7):1105-11. PubMed ID: 17420283
[TBL] [Abstract][Full Text] [Related]
9. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
10. Tibolone: a unique version of hormone replacement therapy.
Swegle JM; Kelly MW
Ann Pharmacother; 2004 May; 38(5):874-81. PubMed ID: 15026563
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and tibolone metabolite levels in blood and breast tissue of postmenopausal women recently diagnosed with early-stage breast cancer and treated with tibolone or placebo for 14 days.
Kloosterboer HJ; Löfgren L; von Schoulz E; von Schoultz B; Verheul HA
Reprod Sci; 2007 Feb; 14(2):151-9. PubMed ID: 17636226
[TBL] [Abstract][Full Text] [Related]
12. Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs).
Wang M; Ebmeier CC; Olin JR; Anderson RJ
Steroids; 2006 May; 71(5):343-51. PubMed ID: 16360722
[TBL] [Abstract][Full Text] [Related]
13. Tissue-selectivity: the mechanism of action of tibolone.
Kloosterboer HJ
Maturitas; 2004 Aug; 48 Suppl 1():S30-40. PubMed ID: 15337246
[TBL] [Abstract][Full Text] [Related]
14. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
Ederveen AG; Kloosterboer HJ
J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834
[TBL] [Abstract][Full Text] [Related]
15. The need for tissue selective menopausal agents.
Eden J
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
[TBL] [Abstract][Full Text] [Related]
16. Tibolone and its metabolites induce antimitogenesis in human coronary artery smooth muscle cells: role of estrogen, progesterone, and androgen receptors.
Dubey RK; Gillespie DG; Grögli M; Kloosterboer HJ; Imthurn B
J Clin Endocrinol Metab; 2004 Feb; 89(2):852-9. PubMed ID: 14764805
[TBL] [Abstract][Full Text] [Related]
17. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
18. Regulation of SULT1E1 expression in Ishikawa adenocarcinoma cells by tibolone.
Falany JL; Falany CN
Steroids; 2006 Oct; 71(10):880-5. PubMed ID: 16857224
[TBL] [Abstract][Full Text] [Related]
19. Tibolone and metabolites induce prolactin production in human endometrial stromal cells in vitro: evidence for cell-specific metabolism.
Groothuis PG; De Gooyer ME; ten Kate J; Menheere PP; Dunselman GA; de Goeij AF; Verbost P; Ederveen AG; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):152-60. PubMed ID: 16781141
[TBL] [Abstract][Full Text] [Related]
20. Tibolone: a steroid with a tissue-specific mode of action.
Kloosterboer HJ
J Steroid Biochem Mol Biol; 2001; 76(1-5):231-8. PubMed ID: 11384882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]